NNovo Nordisk Read More Novo Nordisk’s Strategic Pivot Gains Traction as Clinical Data and Analyst Forecast Align2026-05-14 Novo Nordisk divests last cell therapy asset to double down on obesity; new data shows Wegovy’s 28% weight…